These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2559892)

  • 41. Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis.
    Guirakhoo F; Zhang ZX; Chambers TJ; Delagrave S; Arroyo J; Barrett AD; Monath TP
    Virology; 1999 May; 257(2):363-72. PubMed ID: 10329547
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An assessment of the interval between booster doses of Japanese encephalitis vaccine in the Torres Strait.
    Hanna JN; Smith GA; McCulloch BG; Taylor CT; Pyke AT; Brookes DL
    Aust N Z J Public Health; 2005 Feb; 29(1):44-7. PubMed ID: 15782871
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enhancing the utility of a prM/E-expressing chimeric vaccine for Japanese encephalitis by addition of the JEV NS1 gene.
    Ishikawa T; Wang G; Widman DG; Infante E; Winkelmann ER; Bourne N; Mason PW
    Vaccine; 2011 Oct; 29(43):7444-55. PubMed ID: 21798299
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antibody persistence following booster vaccination against tick-borne encephalitis: 3-year post-booster follow-up.
    Rendi-Wagner P; Paulke-Korinek M; Kundi M; Wiedermann U; Laaber B; Kollaritsch H
    Vaccine; 2007 Jun; 25(27):5097-101. PubMed ID: 17555850
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Study on the protective efficacy of SA14-14-2 attenuated Japanese encephalitis against different JE virus isolates circulating in China.
    Liu X; Yu Y; Li M; Liang G; Wang H; Jia L; Dong G
    Vaccine; 2011 Mar; 29(11):2127-30. PubMed ID: 21237278
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Assessment of neutralizing antibodies elicited by a vaccine (Nakayama) strain of Japanese encephalitis virus in Taiwan.
    Shyu WR; Wang YC; Chin C; Chen WJ
    Epidemiol Infect; 1997 Aug; 119(1):79-83. PubMed ID: 9287947
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Long-term seroprotection against Japanese encephalitis using an inactivated vaccine (Jevax)].
    Van der Vliet D; Simons de Fanti A; Murri S; Lapidus N; Goujon C; Zeller H; Consigny PH
    Med Trop (Mars); 2010 Apr; 70(2):155-7. PubMed ID: 20486351
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Analysis of immune response to Japanese encephalitis virus infection in mice: effect of cyclosporin A on the production of HI antibody and interferon].
    Kushimoto K
    Fukuoka Igaku Zasshi; 1993 Dec; 84(12):512-9. PubMed ID: 8307549
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long term immunity following a booster dose of the inactivated Japanese Encephalitis vaccine IXIARO®, IC51.
    Eder S; Dubischar-Kastner K; Firbas C; Jelinek T; Jilma B; Kaltenboeck A; Knappik M; Kollaritsch H; Kundi M; Paulke-Korinek M; Schuller E; Klade CS
    Vaccine; 2011 Mar; 29(14):2607-12. PubMed ID: 21288804
    [TBL] [Abstract][Full Text] [Related]  

  • 50. TBE booster immunization according to the rapid immunization schedule: are 3-year booster intervals really necessary?
    Zent O; Plentz A; Schwarz TF; Frühwein N; Kuhr HB; Broeker M; Banzhoff A; Jilg W
    Vaccine; 2004 Dec; 23(3):312-5. PubMed ID: 15530673
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A field study on Nakayama and Beijing strains of Japanese encephalitis vaccines.
    Nimmannitya S; Hutamai S; Kalayanarooj S; Rojanasuphot S
    Southeast Asian J Trop Med Public Health; 1995 Dec; 26(4):689-93. PubMed ID: 9139377
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparative study of protection by Japanese encephalitis (JE) vaccine against a Japanese strain and an Indian strain of JE virus.
    Das BC; Chakrabarti SK; Sarkar JK; Mukherjee KK
    Indian J Pathol Microbiol; 1976 Oct; 19(4):239-43. PubMed ID: 191395
    [No Abstract]   [Full Text] [Related]  

  • 53. Japanese encephalitis immunization in South Korea: past, present, and future.
    Sohn YM
    Emerg Infect Dis; 2000; 6(1):17-24. PubMed ID: 10653564
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effect of cytoxan on immune response of Japanese encephalitis virus killed and live vaccines].
    Fang QA; Chen BQ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1989 Oct; 11(5):317-21. PubMed ID: 2561510
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neutralizing antibody response to Japanese encephalitis inactivated mouse brain vaccine among laboratory personnel.
    Rodrigues FM; Mohan Rao CV; Mandke VB; Pinto BD; Pavri K
    Trans R Soc Trop Med Hyg; 1986; 80(2):301-4. PubMed ID: 3024366
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Field experiments on live attenuated Japanese encephalitis virus vaccine for swine.
    Ueba N; Kimura T; Nakajima S; Kurimura T; Kitaura T
    Biken J; 1978 Sep; 21(3):95-103. PubMed ID: 219844
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A community-based study of subclinical flavivirus infections in children in an area of Tamil Nadu, India, where Japanese encephalitis is endemic.
    Gajanana A; Thenmozhi V; Samuel PP; Reuben R
    Bull World Health Organ; 1995; 73(2):237-44. PubMed ID: 7743596
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epidemiological and ecological studies of Japanese encephalitis in Okinawa, subtropical area in Japan. II. Prevalence of Japanese encephalitis antibody in residents in Okinawa, Miyako and Ishigaki islands.
    Tadano M; Kanemura K; Arakaki S; Makino Y; Fukunaga T; Hokama T; Kyan T; Makiya H; Taira Y; Ohama N
    Microbiol Immunol; 1994; 38(2):123-8. PubMed ID: 8041299
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunogenicity of low dose Japanese encephalitis vaccine (BIKEN) administered by the intradermal route: preliminary data.
    Intralawan P; Paupunwatana S
    Asian Pac J Allergy Immunol; 1993 Jun; 11(1):79-83. PubMed ID: 8216563
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Japanese encephalitis vaccine: persistence of antibody up to 3 years after a three-dose primary series.
    Gambel JM; DeFraites R; Hoke C; Brown A; Sanchez J; Karabatsos N; Tsai T; Meschievitz C
    J Infect Dis; 1995 Apr; 171(4):1074. PubMed ID: 7706798
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.